NUZ neurizon therapeutics limited

2.94%

17.5¢

Ann: Neurizon updates on NUZ-001 IND Application, page-391

First 391 Last

Share
Profile

Follow
Quiltman

2,733 Posts.

3669

12/03/25

22:06

Post #: 78241304
Share

Originally posted by gavros: ↑

A response from MT on the investor hub to a question that someone submitted just yesterday. Sheds a bit more light on the current situation:

“Hi ND, I apologise if the shareholders are unclear about the nature of the FDA's request. As previously communicated to the market, the FDA requires additional exposure data (i.e., blood levels of NUZ-001 in rats and dogs) to ensure they have the necessary confidence that there will be no potential safety concerns for humans arising from the various toxicity studies conducted. We have been collaborating with Elanco and the FDA to establish the quickest path forward in providing this data. We have now submitted a request for advice to the FDA along with our proposed work plan to gather this information. Once we receive confirmation from the FDA that our proposed work plan is satisfactory, we will advise the market accordingly and outline a timeline for lifting the clinical hold. Please note there is no statutory timeline for the FDA to respond, but we are hopeful for a prompt reply given our recent interactions and the minor nature of our advice request.Regarding our position in the HEALEY Platform Trial, that hasn’t changed because we are confident, and so is HEALEY, about lifting the clinical hold soon. If anything, the delay has aligned our regimen more closely with upcoming additional regimens. This is a significant development for Neurizon as we need these extra regimens to run alongside ours to gain the maximum benefit (i.e. shared placebo) from the platform trial. Thanks for your question. MichaelPS. There is no real limitations as to how many regimens HEALEY can run concurrently. If the number is 4, they will run 4.”

Expand

A quick 2 second search on AI.

NUZ-001 running at 10 mg/kg body weight per day on current OLE study and proposed HEALEY Trial.
Looks like FDA is looking for some clarification on these studies around blood levels of monepantel and/or it's sulfone metabolite.

....

NUZ Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
19 Upvote

2 Great analysis

Reply

Top Stories

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

PIQ

Proteomics notches up as company launches PromarkerD into the US

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

First 391 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.5¢		Change 0.005(2.94%)		Mkt cap ! $86.15M

Open	High	Low	Value	Volume
17.0¢	18.5¢	16.5¢	$91.76K	527.0K

Buyers (Bids)

No.	Vol.	Price($)
4	80407	17.0¢

Sellers (Offers)

Price($)	Vol.	No.
17.5¢	31	1

View Market Depth

No.	Vol.	Price($)
4	80407	0.170
2	23629	0.165
6	224452	0.160
2	20000	0.155
4	316500	0.150

Price($)	Vol.	No.
0.175	31	1
0.185	150125	4
0.190	24925	2
0.195	81250	2
0.200	251140	3

Last trade - 15.34pm 20/06/2025 (20 minute delay)

NUZ (ASX) Chart

Ann: Neurizon updates on NUZ-001 IND Application, page-391

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Proteomics notches up as company launches PromarkerD into the US

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Novo flags antimony and gold in the Pilbara – but does it need to step back?

AML3D opens new facility in Ohio as US Defence strategy bears fruit

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Neurizon updates on NUZ-001 IND Application, page-391

Top Stories

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Proteomics notches up as company launches PromarkerD into the US

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Novo flags antimony and gold in the Pilbara – but does it need to step back?

AML3D opens new facility in Ohio as US Defence strategy bears fruit

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News